These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20966139)

  • 1. International pharmacists group meets in Lisbon: New policy statement seeks to advance collaborative practice.
    Thompson CA
    Am J Health Syst Pharm; 2010 Nov; 67(21):1793-4, 1796. PubMed ID: 20966139
    [No Abstract]   [Full Text] [Related]  

  • 2. Expanding knowledge and opportunity in pharmacy.
    Wehrli A
    Am J Health Syst Pharm; 2011 Mar; 68(5):426-32. PubMed ID: 21330685
    [No Abstract]   [Full Text] [Related]  

  • 3. Oncology pharmacy practice as a model for international collaborations.
    Goldspiel BR
    Am J Health Syst Pharm; 2012 Jun; 69(11):951-7. PubMed ID: 22610027
    [No Abstract]   [Full Text] [Related]  

  • 4. The infancy of an international pediatric pharmacy network.
    Knoppert D; Arenas-Lopez S; McArtney R
    Paediatr Drugs; 2008; 10(2):71-3. PubMed ID: 18345716
    [No Abstract]   [Full Text] [Related]  

  • 5. Advancing pharmacy practice through policies: development, debate, and consensus in the APhA House of Delegates.
    Boyle CJ; Lipowski EE; Vernon V
    J Am Pharm Assoc (2003); 2011; 51(4):462-5. PubMed ID: 21752766
    [No Abstract]   [Full Text] [Related]  

  • 6. ASHP Statement on the Role of Health-System Pharmacists in Public Health.
    American Society of Health-System Pharmacists
    Am J Health Syst Pharm; 2008 Mar; 65(5):462-7. PubMed ID: 18281740
    [No Abstract]   [Full Text] [Related]  

  • 7. ASHP statement on criteria for an intermediate category of drug products.
    American Society of Health-System Pharmacists
    Am J Health Syst Pharm; 2009 Mar; 66(5):502-5. PubMed ID: 19241626
    [No Abstract]   [Full Text] [Related]  

  • 8. APhA2017 House of Delegates: Opportunities for collaboration: The impact of science and research on pharmacy practice.
    Urick B
    J Am Pharm Assoc (2003); 2017; 57(4):429-430. PubMed ID: 28712459
    [No Abstract]   [Full Text] [Related]  

  • 9. Health care reform law offers opportunities for pharmacists.
    Batshon L
    Consult Pharm; 2010 Jun; 25(6):388. PubMed ID: 20534410
    [No Abstract]   [Full Text] [Related]  

  • 10. APhA2008 House of Delegates: Advancing current practice, preserving pharmacy integrity for the future.
    Marciniak MW; Ried LD; Lipowski EE; Skelton Duke MV
    J Am Pharm Assoc (2003); 2008; 48(4):447-8, 451-4. PubMed ID: 18653416
    [No Abstract]   [Full Text] [Related]  

  • 11. ASHP guidelines on home infusion pharmacy services.
    Petroff BJ; Filibeck D; Nowobilski-Vasilios A; Olsen RS; Rollins CJ; Johnson C
    Am J Health Syst Pharm; 2014 Feb; 71(4):325-41. PubMed ID: 24481158
    [No Abstract]   [Full Text] [Related]  

  • 12. Treat the patient and not the number: A call to care.
    Alvarez NA
    J Am Pharm Assoc (2003); 2017; 57(4):431-434. PubMed ID: 28712460
    [No Abstract]   [Full Text] [Related]  

  • 13. Why You Should Become an International Academy of Compounding Pharmacists Member.
    Gates EP
    Int J Pharm Compd; 2017; 21(1):28. PubMed ID: 28346195
    [No Abstract]   [Full Text] [Related]  

  • 14. International pharmacy group to pursue better medication access in developing countries: ASHP casts lone 'nay' on doping-in-sport statement.
    Thompson CA
    Am J Health Syst Pharm; 2005 Nov; 62(21):2216, 20. PubMed ID: 16239406
    [No Abstract]   [Full Text] [Related]  

  • 15. Report of the APhA and APhA-ASP Houses of Delegates.
    Bzowyckyj A; Oestreich J; Kirk LM
    J Am Pharm Assoc (2003); 2015; 55(4):340, 342-4, 346-7. PubMed ID: 26161477
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacy practice around the world.
    Lutz EM; Rovers J; Mattingly J; Reed BN
    J Am Pharm Assoc (2003); 2009; 49(1):4-11. PubMed ID: 19196590
    [No Abstract]   [Full Text] [Related]  

  • 17. Need for greater continuity of care.
    Manasse HR; Menighan TE
    Am J Health Syst Pharm; 2011 Mar; 68(6):476, 478. PubMed ID: 21378293
    [No Abstract]   [Full Text] [Related]  

  • 18. Advocacy: the essential competence.
    Boyle CJ
    J Am Pharm Assoc (2003); 2009; 49(3):364, 366. PubMed ID: 19443317
    [No Abstract]   [Full Text] [Related]  

  • 19. Richly blessed or simply lucky: Lessons learned on the road to Remington.
    Maine LL
    J Am Pharm Assoc (2003); 2019; 59(4):e8-e11. PubMed ID: 31296327
    [No Abstract]   [Full Text] [Related]  

  • 20. Achieving recognition as patient-centered care providers: we are our own best advocates.
    Cooke RL; Lipowski E; Magness JW
    J Am Pharm Assoc (2003); 2013; 53(3):234, 236-8. PubMed ID: 23699671
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.